Beneficial effects of intracoronary urapidil as an adjunct to primary angioplasty in acute myocardial infarction

YAO Daokuo,JIA Sanqing,WANG Lei,LI Hongwei,ZHANG Yuchen,WANG Yongliang,WANG Yupeng,ZHAO Lin,DING Rongjing

DOI: https://doi.org/10.3969/j.issn.1007-5062.2007.04.002

2007-01-01

Abstract:Objective:The aim of this study was to evaluate the effect of urapidil on myocardial reperfusion and heart function during primary percutenous coronary intervention(PCI)in acute myocardial infarction(AMI)patients.Method:Fifty and four AMI patients undergoing primary PCI were randomized to intracoronary urapidil,nitroglycerin or saline group.Before percutenous transluminal coronary angioplasty,urapidil,nitroglycerin or saline were given intracoronary and then stents were implanted as needed.TIMI blood flow,corrected TIMI frame count,myocardial blush grade,ST resolution on ECG,left ventricular eject fraction,major adverse cardiac events were observed.Result:Final TIMI blood flow,cTFC and MBG improved in the urapidil group(compared to the nitroglycerin and control group,P<0.01,respectively).ST resolution in the urapidil group was more significant than that of the nitroglycerin and control group(P<0.01,respectively).LVEF in the urapidil group was higher than that of the nitroglycerin and control group(P<0.01).Conclusion:Conclusions:Intracoronary urapidil administration adjunct to primary PCI in AMI ameliorates coronary blood flow and myocardial perfusion,improves ventricular function,and is associated with a more favorable clinical course.